Activist Altai Capital Launches Proxy Fight, Demands Strategic Review & Board Seats at OraSure

summarizeSummary

Activist shareholder Altai Capital Management, holding a 5% stake, has launched a proxy contest, publicly detailing its "five-pillar case for change" and demanding board representation to initiate a strategic review, including a potential sale of the company.

check_boxKey Events

• Activist Proxy Contest Launched

  Altai Capital Management, a 5% shareholder, publicly launched a proxy contest, detailing its "five-pillar case for change" and demanding board seats for its nominees, Rishi Bajaj and John Bertrand.

• Call for Strategic Review and Potential Sale

  Altai Capital is pushing for a comprehensive strategic review, including evaluating a sale of the entire business, which they estimate could yield $4.54 to $6.60 per share, representing a 42% to 107% premium to the current stock price.

• Criticism of Underperformance and Governance

  The activist highlighted OraSure's chronic stock underperformance, the board's low share ownership, and CEO compensation not tied to share price, especially following significant financial losses reported in the recent 10-K.

• Board Resignations Noted

  The filing notes the resignation of Mara Aspinall from the board in October 2025, after Altai's discussions made clear they would seek her replacement.

auto_awesomeAnalysis

This DFAN14A filing signals a significant escalation in the activist campaign by Altai Capital, one of OraSure's largest shareholders. The detailed letter outlines severe criticisms of OraSure's chronic underperformance, board oversight, and CEO compensation, particularly in light of recent substantial financial losses reported in the 10-K on March 9, 2026. Altai's call for a strategic review, including a potential sale of the entire business at a significant premium to the current share price, presents a major catalyst for the stock. The ongoing public dispute, evidenced by the company's defensive statement on the same day, indicates a contentious battle for control and strategic direction. Investors should closely monitor developments in this proxy contest, as the outcome could lead to fundamental changes in OraSure's operations or ownership structure.